Search results
Results from the WOW.Com Content Network
Piramal Pharma Limited is active in business verticals including pharmaceuticals, healthcare and life sciences.Its business divisions include Piramal Pharma Solutions, a contract development and manufacturing organization; Piramal Critical Care, a manufacturer of inhalational anesthetics and other hospital generics; and Piramal Consumer Products Division, an over-the-counter consumer ...
Ajay Gopikisan Piramal (born 3 August 1955) is an Indian billionaire businessman, and the chairman of the Piramal Group, a conglomerate with interests in pharmaceutical, financial services, real estate, healthcare analytics and glass packaging. [1] [2] As of July 2024, his net worth is estimated at US$2.8 billion. [3]
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
Swati Ajay Piramal (née Shah; born 28 March 1956) is an Indian scientist and businesswoman, she also involved in healthcare, focusing on public health and innovation. She is the vice chairperson of Piramal Group, a business conglomerate with interests in pharmaceuticals, financial services, real estate and glass packaging.
Prior to its acquisition by the Piramal Group in 1984, the company's manufacturing plant was located in Kosamba, Gujarat. In 1990, Gujarat Glass Pvt. Ltd. merged with its parent company Nicholas Piramal India Ltd. to become one of its many divisions. [4] [5] In 2020, The Blackstone Group announced that it would acquire Piramal Glass for US$ 1 ...
Anjalee Khemlani is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, care services, digital health, PBMs, and health policy and politics. That includes GLP-1s ...
In the last seven days, Yahoo Finance data shows 23 analysts have pushed up their earnings per share estimates on Meta for 2025. A total of 20 analysts have hiked their EPS projections for 2026 in ...
Profits came out to $20 billion while earnings per share reached $1.86, higher than the $1.49 that analysts surveyed by FactSet had anticipated. Amazon reports strong earnings for Q4, but stocks ...